Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Tennessee and South Carolina joined 48 others in a $17.85M settlement with Lannett and Bausch Health over price-fixing in generic drugs from 2009 to 2019.
Tennessee and South Carolina joined 48 other states and territories in securing a $17.85 million settlement with Lannett and Bausch Health over allegations they conspired to inflate generic drug prices from 2009 to 2019.
The companies admitted to anti-competitive behavior, including price-fixing and market manipulation, and agreed to cooperate in ongoing multistate litigation, implement compliance reforms, and help recover funds for affected consumers.
The case stems from a 2016 investigation involving millions of documents and call records, with evidence of collusion through social events and coded discussions.
A trial is expected to begin in late 2026.
Tennessee y Carolina del Sur se unieron a otras 48 en un acuerdo de $17.85M con Lannett y Bausch Health por la fijación de precios en medicamentos genéricos desde 2009 hasta 2019.